Category Archives: Antibiotic Resistance

Research – Antibiotic Resistant Escherichia coli in Uncooked Meat Purchased from Large Chain Grocery Stores and in Raw Dog Food Purchased From Pet Stores in the Same City

BIORXIV

Abstract

Although previous studies have associated feeding dogs uncooked meat with their carriage and excretion of antibiotic resistant (ABR) Escherichia coli, this practice remains popular amongst dog owners in some countries, including the UK. Uncooked meat fed to dogs is purchased from stores selling meat primarily for human consumption, or it is a brand of commercial raw dog food (RDF), which is commonly sold frozen and thawed prior to feeding. We tested 58 packets of uncooked meat (beef, chicken, lamb and pork) purchased from large chain grocery stores (15 stores) and 15 packets of thawed, chicken-based RDF (11 brands) for the presence of ABR E. coli. All samples were purchased from the city of Bristol, UK. Among grocery store-purchased meat, chicken samples were significantly more likely to be positive for E. coli resistant to amoxicillin, spectinomycin, streptomycin, and the critically important antibiotics cefotaxime and ciprofloxacin, than other types of meat. When comparing grocery store chicken to chicken-based RDF we found no significant difference in sample-level positivity for resistant E. coli, which, for RDF was 80% (amoxicillin), 80% (spectinomycin), 87% (streptomycin), 27% (amoxicillin-clavulanate), 27% (cefotaxime) and 47% (ciprofloxacin). We conclude that despite it having been purchased frozen and thawed prior to testing according to the manufacturer’s instructions, contamination of RDF with ABR E. coli is similar to that of uncooked meat primarily intended for human consumption after cooking, and so the same strict hygiene practices are advised when handling RDF as uncooked meat. Our findings provide a rationale to explain why feeding uncooked meat or RDF to dogs in the city of Bristol is associated with them excreting E. coli resistant to critically important antibiotics.

Research – Multistate nontyphoidal Salmonella and Shiga toxin-producing Escherichia coli outbreaks linked to international travel—United States, 2017–2020

Cambridge.org

Abstract

Enteric bacterial infections are common among people who travel internationally. During 2017–2020, the Centers for Disease Control and Prevention investigated 41 multistate outbreaks of nontyphoidal Salmonella and Shiga toxin-producing Escherichia coli linked to international travel. Resistance to one or more antimicrobial agents was detected in at least 10% of isolates in 16 of 30 (53%) nontyphoidal Salmonella outbreaks and 8 of 11 (73%) Shiga toxin-producing E. coli outbreaks evaluated by the National Antimicrobial Resistance Monitoring System. At least 10% of the isolates in 14 nontyphoidal Salmonella outbreaks conferred resistance to one or more of the clinically significant antimicrobials used in human medicine. This report describes the epidemiology and antimicrobial resistance patterns of these travel-associated multistate outbreaks. Investigating illnesses among returned travellers and collaboration with international partners could result in the implementation of public health interventions to improve hygiene practices and food safety standards and to prevent illness and spread of multidrug-resistant organisms domestically and internationally.

EU – Zoonoses, foodborne outbreaks and antimicrobial resistance guidance for reporting 2023 data

EFSA

This technical report provides guidance for reporting countries on how to submit their isolate-based quantitative antimicrobial resistance data, and data on the prevalence of zoonoses and microbiological agents and contaminants in food, food-borne outbreaks, animal populations and disease status. To collect these data, EFSA has created the Data Collection Framework (DCF) application. This report includes data dictionaries to guide the reporting of information derived from 2023 under Directive 2003/99/EC, Regulation (EU) 2017/625, Commission Implementing Regulation (EU) 2019/627 and Commission Implementing Decision (EU) 2020/1729. The objective is to explain in detail the individual data elements of the EFSA data models that are to be used for XML data submission through the DCF. In particular, it explains the data elements to be reported, including information about the data type, a reference to the list of permitted terms and any additional business rules or requirements that may apply.

Research – Salmonella in horses at slaughter and public health effects in Italy

Science Direct

Abstract

The study assessed the role of equids at slaughter as faecal carriers of Salmonella enterica and the occurrence of contaminated equid carcasses during the slaughter process in Northern Italy (Emilia-Romagna Region). From June to November 2021, 152 equids (146 horses, 5 donkeys and 1 mule) were tested for Salmonella both in caecal contents and through carcass swabs. Antimicrobial resistance (AMR) of recovered strains was tested against 15 antimicrobials. Salmonella was detected in 3/152 of the caecal contents (2.0 %), while all carcass samples were negative. S. enterica serovars Enteriditis, Typhimurium and Stanleyville were identified. The only AMR isolate was S. Typhimurium with AMR profile AmCStxT.

Considering the consumption of raw horse meat (i.e., minced raw meat named “pesto di cavallo” and dried and smoked strips named “sfilacci di cavallo”) in different areas of Northern Italy, we also investigated the possible link between horse meat eating and salmonellosis cases in the human population in the same area. Specifically, we compared the Salmonella strains collected during the study with those routinely processed in the laboratory surveillance system for human salmonellosis in Emilia-Romagna (a region with about 4.5 million inhabitants). The comparison was based on whole genome sequencing data through core genome multi-locus sequence typing (cgMLST) used in routine surveillance. A genomic match in cgMLST was found between the strain of S. enterica serovar Enteritidis isolated from a horse caecal content and an enduring outbreak of 17 human cases in Emilia-Romagna during the study period. The consequent epidemiological investigation highlighted that a number of cases with known food history reported the consumption of horse meat and traced different batches of the consumed meat, released weeks apart from each other, to the slaughter investigated in the study. The results of the epidemiological investigation suggested the role of horses in the S. enterica serovar Enteritidis outbreak affecting raw horse meat consumers.

This study shows that, despite the low prevalence on equid carcasses, S. enterica in horse meat can represent a risk to consumers. From the perspective of the slaughter activities, this highlights the need to maintain a high level of hygiene during the entire process, starting from the hygiene at lairage up to the slaughtering phase and dressing of carcasses.

Research – Predictive Mapping of Antimicrobial Resistance for Escherichia coli, Salmonella, and Campylobacter in Food-Producing Animals, Europe, 2000–2021

cdc

Abstract

In Europe, systematic national surveillance of antimicrobial resistance (AMR) in food-producing animals has been conducted for decades; however, geographic distribution within countries remains unknown. To determine distribution within Europe, we combined 33,802 country-level AMR prevalence estimates with 2,849 local AMR prevalence estimates from 209 point prevalence surveys across 31 countries. We produced geospatial models of AMR prevalence in Escherichia coli, nontyphoidal Salmonella, and Campylobacter for cattle, pigs, and poultry. We summarized AMR trends by using the proportion of tested antimicrobial compounds with resistance >50% and generated predictive maps at 10 × 10 km resolution that disaggregated AMR prevalence. For E. coli, predicted prevalence rates were highest in southern Romania and southern/eastern Italy; for Salmonella, southern Hungary and central Poland; and for Campylobacter, throughout Spain. Our findings suggest that AMR distribution is heterogeneous within countries and that surveillance data from below the country level could help with prioritizing resources to reduce AMR.

Research – Sweet and sour synergy: exploring the antibacterial and antibiofilm activity of acetic acid and vinegar combined with medical-grade honeys

Microbiology Society

ABSTRACT

, a combination of honey and vinegar, has been used as a remedy for wounds and infections in historical and traditional medical settings. While honey is now clinically used to treat infected wounds, this use of a complex, raw natural product (NP) mixture is unusual in modern western medicine. Research into the antimicrobial activity of NPs more usually focuses on finding a single active compound. The acetic acid in vinegar is known to have antibacterial activity at low concentrations and is in clinical use to treat burn wound infections. Here, we investigated the potential for synergistic activity of different compounds present in a complex ingredient used in historical medicine (vinegar) and in an ingredient mixture (). We conducted a systematic review to investigate published evidence for antimicrobial effects of vinegars against human pathogenic bacteria and fungi. No published studies have explicitly compared the activity of vinegar with that of a comparable concentration of acetic acid. We then characterized selected vinegars by HPLC and assessed the antibacterial and antibiofilm activity of the vinegars and acetic acid, alone and in combination with medical-grade honeys, against and . We found that some vinegars have antibacterial activity that exceeds that predicted by their acetic acid content alone, but that this depends on the bacterial species being investigated and the growth conditions (media type, planktonic vs. biofilm). Pomegranate vinegars may be particularly interesting candidates for further study. We also conclude that there is potential for acetic acid, and some vinegars, to show synergistic antibiofilm activity with manuka honey.

UK – FSA – Understanding antimicrobial resistance in foodborne pathogens

Gov UK

Our IID3 project will include an assessment of antimicrobial resistance (AMR) in bacterial pathogens; the first IID project to do so. A better understanding of AMR in foodborne pathogens will support our contribution to the UK’s AMR National Action Plan.

Some bacteria that cause food poisoning are antimicrobial resistant (AMR). This means that antibiotics are ineffective, and infections are difficult or impossible to treat. Addressing the challenge of AMR and strengthening our knowledge about its implications, the bacteria that are most resistant and the antibiotics that they are resistant to, is crucial. If left unchecked, the increase of AMR could lead to the risk of disease being spread. Through projects such as IID3, we are able to learn more about AMR in foodborne pathogens with the aim of supporting work to prevent the spread.

New Zealand Research – Superbugs: how you can help fight back

MPI

New Zealand Food Safety is fighting back against superbugs – antimicrobial resistance (AMR) – and we need your help.

“The World Health Organization has identified AMR as one of the top 10 global health threats facing humanity,” says New Zealand Food Safety deputy director-general Vincent Arbuckle.

“World Antimicrobial Awareness Week, which begins tomorrow, recognises that this serious issue will need a global effort to manage. This year’s theme is ‘preventing antimicrobial resistance together’.”

AMR occurs when microbes, or germs, develop resistance to medicines, such as antibiotics. Antimicrobial medicines are critical to human, animal, and plant health, as well as the environment, but they lose effectiveness over time if they are not properly handled and disposed of.

“Antibiotic medicines are essential to the health of humans, animals, and plants. If they are not used properly, diseases can develop resistance, which makes the medicine less effective,” says Mr Arbuckle.

“Everyone has a role to play to ensure the appropriate use and disposal of antibiotics in their care to prevent the spread of AMR in humans, animals, plants, and the environment.

“New Zealand Food Safety works to reduce AMR risks in domestic animals, livestock and plants with a dedicated team that works with the New Zealand veterinary and primary industry sectors to promote careful use of antibiotics and encourage infection prevention strategies such as good hygiene and vaccination, and undertake surveillance for resistance in bacteria collected from animal samples.”

Here’s what pet owners and livestock farmers can do to help reduce the risk:

  • Take measures to keep animals healthy, such as keeping up them up to date with vaccinations and using good hygiene and biosecurity.
  • If antibiotics are needed, closely follow the instructions outlined by your veterinarian. Make sure you give the correct dose, at the right time of day, and for the prescribed duration.
  • Wash your hands after dosing and handling animals.
  • Make sure your animal completes the prescribed course. If for some reason you are unable to complete the course, let your veterinarian know so they can help you.
  • Never keep antibiotics for future use because each infection and animal need unique treatment.
  • Dispose of the empty containers appropriately to help keep the environment safe.

“In further good news, our 2022 Antibiotic agricultural compound sales analysis shows quantities of antibiotics used in animals have been declining for the last 5 years, with a 23% reduction. However we need to continue our efforts to preserve the effectiveness of lifesaving medicines,” says Mr Arbuckle.

Media release: Sales of antibiotics used in animals and plants down by nearly a quarter

New Zealand Food Safety takes a One Health approach to AMR, working closely with the Ministry of Health including on the joint New Zealand antimicrobial resistance action plan – with an updated plan due for publication in 2024.

New Zealand antimicrobial resistance action plan [PDF, 836KB] 

Find out more

For further information and general enquiries, call MPI on 0800 00 83 33 or email info@mpi.govt.nz

Research – Prevalence of Multidrug-Resistant Pseudomonas aeruginosa Isolated from Dairy Cattle, Milk, Environment, and Workers’ Hands

MDPI

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen causing severe infection in animals and humans. This study aimed to determine the ecological distribution and prevalence of multidrug-resistant (MDR) P. aeruginosa isolated from dairy cattle, the environment, and workers’ hand swabs. Samples (n = 440) were collected from farms and households (n = 3, each). Rectal swabs, udder skin swabs, milk, workers’ hand swabs, feed, water, water sources, and beddings were collected. Samples were subjected to the bacterial identification of P. aeruginosa via 16S rRNA. Antimicrobial resistance (AMR) was detected either phenotypically using an antibiotic susceptibility test or genotypically with AMR resistance genes (ARGs) such as drfA, sul1, and ermB. P. aeruginosa was detected on dairy farms and households (10.3–57.5%, respectively), with an average of 23.2%. The resistance of dairy farm strains was observed against sulfamethoxazole, imipenem, cefepime, piperacillin–tazobactam, and gentamycin (100%, 72.7%, 72.7%, 68.8%, and 63.3%, respectively). Meanwhile, the resistance of household strains was observed against sulfamethoxazole, imipenem, amoxicillin, gentamicin, cefepime, and erythromycin by 91.3%, 82.6%, 75.4%, 75.4%, 68.1%, and 63.8%, respectively. The susceptibility of farm strains was detected against norfloxacin, ciprofloxacin, and levofloxacin (90.9%, 84.8%, and 72.7%, respectively). Meanwhile, the susceptibility of household strains was detected against ciprofloxacin, amikacin, and norfloxacin (100%, 84.1%, and 72.5%, respectively). About 81.4% of P. aeruginosa strains were MDR. ARGs (drfA, sul1, and ermB) were detected in farm strains (48.5%, 72.7%, and 24.4%, respectively) and household strains (50.7%, 72.5%, and 47.8%, respectively). Almost all P. aeruginosa had MAR over 0.2, indicating repeated application of antibiotics. P. aeruginosa prevalence was fivefold higher in households than on farms. MDR strains were higher amongst household strains than farm strains.

What are Extensively Drug Resistant (XDR) Bacteria?

News Medical

Resistance to antimicrobial agents is a growing and worrying phenomenon. Extensively drug-resistant bacteria, or XDR bacteria, are a type of multidrug-resistant organisms that are resistant to almost all or all approved antimicrobial agents.

The origin of XDR bacteria

The term was first coined in response to Mycobacterium tuberculosis that was resistant to first-line agents (isoniazid and rifampicin), a fluoroquinolone, and to one or more second-line parenteral drugs (amikacin, kanamycin, and capreomycin). This was later expanded to include other bacteria that were resistant to most standard antimicrobial treatments.

Defining XDR bacteria

XDR bacteria are different from multidrug-resistant bacteria and pan-drug resistant bacteria. The difference is mainly interpreted as to what extent the bacteria are drug-resistant, with multidrug-resistant bacteria being unsusceptible to one or more antimicrobial agents and pan-drug resistant bacteria being unsusceptible to all antimicrobial agents.

Therefore, XDR bacteria rest somewhere in between these two categories. Occasionally, definitions are based on broader categories of antimicrobials rather than agents, which therefore narrows the bacteria fitting the description. However, this system is often seen as more informative by healthcare professionals treating afflicted patients with various antimicrobial classes.

Read more at the link above